translational medicine

user Mrd7b2 / Wikipedia

On November 5, Jackson County voters will decide whether to fund a translational medicine institute. A proposed half-cent sales tax would raise $800 million over the next 20 years to be divided among Children’s Mercy Hospital, St. Luke’s Hospital and the University of Missouri-Kansas City School of Medicine.

Ten percent of the $800 million and 20 percent of profits the program generates would fund local public health initiatives.

theocean/Flickr-CC

Jackson County voters head to the polls on November 5 to vote on a 1/2 cent sales tax increase to fund a translational medicine institute. 

In the first part of Tuesday's Up to Date, a proponent and opponent of the tax meet in our studios to debate the controversial proposal, including how county residents will actually benefit from the project.

Guests:

Children's Mercy Hospital

On Wednesday, the Hall Family Foundation announced that it was pledging $75 million to Children's Mercy Hospital for build a translational medicine research building on Children's Mercy's campus on Hospital Hill.

Wikipedia Commons

The Hall Family Foundation is pledging $75 million to build a research building at Children’s Mercy Hospital, but only if Jackson County voters pass a half-cent medical research sales tax. 

At the hospital Wednesday, foundation president Bill Hall said the tax offers Kansas City a big opportunity.

"We recognize it is asking a great deal of the voters of Jackson County," he said. "However, we believe this is a moment we must seize. The tax is transformational."

Wikipedia Commons

The Jackson County Legislature voted Monday to place a 20-year, half-cent sales tax measure on the November 5 ballot.

Aimed at boosting economic development and funding research, supporters call it a game-changer for Kansas City, a way to bolster the area's claim as a hub of life science research. Opponents haven't galvanized, at least in a visible way. But lots of questions are being raised.

user Mrd7b2 / Wikipedia

Researchers in Kansas City may have developed a way to speed up the diagnosis of critically ill infants with genetic diseases.